The Pharmaceutical Journal
Vol 274 No 7332 p40
15 January 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Hepatitis B treatment

Peginterferon alfa-2b is an effective and well tolerated treatment for chronic hepatitis B, say researchers. What is more, they found that addition of the antiretroviral agent lamivudine does not improve outcomes for patients. The researchers also report that a patient’s hepatitis B virus genotype is an important predictor of response to peginterferon (Lancet 2005;365:123).